LFSC Top Holdings & Constituents
LFSC, offered by F/m, holds 40 reported positions across $74.7M in assets. Its largest holdings are Travere Therapeutics Inc (TVTX) (7.67%), Cogent Biosciences Inc (COGT) (7.53%), and LivaNova PLC (LIVN) (7.11%). The 5 biggest positions account for 34.23% of reported assets. The table below lists every reported holding with its portfolio weight and market value in US dollars — open any constituent to research its own performance.
| Position | Weight | Market Value |
|---|---|---|
TVTX Travere Therapeutics Inc | 7.67% | $8.05M |
COGT Cogent Biosciences Inc | 7.53% | $7.91M |
LIVN LivaNova PLC | 7.11% | $7.47M |
SYRE Spyre Therapeutics Inc | 6.41% | $6.73M |
GH Guardant Health Inc | 5.52% | $5.80M |
Holdings data comes from the latest SEC Form N-PORT-P filing for this fund, covering the reporting period ended May 31, 2026. Market values are reported in US dollars, and each weight represents the position's share of reported fund assets. Cash, derivatives, and rounding can mean displayed weights do not total 100%. Funds rebalance and file on a schedule, so this page may not reflect intraday or post-filing changes.